Skip to content

EssilorLuxottica Expands in Med-Tech with Espansione Group

๐„๐ฌ๐ฌ๐ข๐ฅ๐จ๐ซ๐‹๐ฎ๐ฑ๐จ๐ญ๐ญ๐ข๐œ๐š ๐„๐ฑ๐ฉ๐š๐ง๐๐ฌ ๐ข๐ง ๐Œ๐ž๐-๐“๐ž๐œ๐ก ๐ฐ๐ข๐ญ๐ก ๐„๐ฌ๐ฉ๐š๐ง๐ฌ๐ข๐จ๐ง๐ž ๐†๐ซ๐จ๐ฎ๐ฉ ๐€๐œ๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง

๐Ÿค EssilorLuxottica has announced an agreement to acquire Espansione Group, an Italy-based company renowned for its innovative, non-invasive medical devices. Specializing in technologies for the diagnosis and treatment of dry-eye, ocular surface, and retinal diseases, Espansione Group brings a wealth of expertise and patented solutions to the table.

๐Ÿ‘€ This acquisition marks another step in EssilorLuxotticaโ€™s commitment to advancing eye care through innovation. By integrating Espansione Groupโ€™s cutting-edge products into its portfolio, EssilorLuxottica aims to address the growing global demand for effective treatments for eye conditions while solidifying its leadership in the med-tech space.